We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Molecular Diagnostics

PATHFINDER 2 Study: Screen Detected Cancers (Photo courtesy of GRAIL)

Multi-Cancer Test Boosts Detection When Added to Standard Screening

PATHFINDER 2 study findings show that GRAIL’s Galleri MCED test increased cancer detection 6.5-fold when added to recommended cancer screening. More...
02 Jun 2026
Image: Findings show that MRD‑guided intervention demonstrated the potential to delay or possibly prevent leukemic relapse (image credit: Shutterstock)

Blood-Based MRD Monitoring Supports Relapse Prevention in Leukemia

New long-term data show MRD-triggered therapy may delay or prevent relapse in MDS and AML. More...
01 Jun 2026
Image: The Decipher Prostate test can guide treatment decisions in metastatic prostate cancer (Photo courtesy of Veracyte)

Genomic Test Predicts Chemotherapy Benefit in Metastatic Prostate Cancer

New data show a genomic test predicts which metastatic prostate cancer patients benefit from triplet therapy. More...
01 Jun 2026
Image: New findings shows that specific blood proteins are altered long before multiple sclerosis diagnosis, pointing to a potential approach for pre-symptomatic risk assessment (image credit: Adobe Stock)

Blood Protein Markers Flag Multiple Sclerosis Risk Years Before Diagnosis

Researchers identify plasma proteins altered years before MS, supporting pre-symptomatic risk stratification and prognosis. More...
01 Jun 2026
Image: NHS-Galleri Trial: Percent difference in Stage IV cancers (Photo courtesy of GRAIL)

MCED Blood Test Reduces Stage IV Cancer Diagnoses in NHS Trial

GRAIL reported NHS-Galleri trial findings at ASCO 2026 showing fewer stage IV diagnoses despite missing the combined stage III–IV endpoint. More...
31 May 2026
Image: The updated CRC screening guidance adds a stool RNA test and an updated stool DNA test to the menu of preferred options (image credit: Adobe Stock)

Updated Guidance Prioritizes Stool-Based Colorectal Cancer Screening Tests

Guidelines recommend stool RNA and updated stool DNA tests for CRC screening, limiting blood tests due to lower sensitivity. More...
29 May 2026
Image: The new assays target the nucleoprotein (NP) and VP35 regions of the ebolavirus (image credit: 123RF)

Digital PCR Assays Support Surveillance of Bundibugyo Ebolavirus Outbreak

A new dPCR assay set enables rapid, sensitive Bundibugyo ebolavirus detection for research and wastewater surveillance. More...
29 May 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Portable POCT Blood Gas Analyzer
BD100
All-in-One Molecular System
AIO M160


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.